Nascent Pharma Holdings, Inc. (NASC)
OTCMKTS · Delayed Price · Currency is USD
0.01181
+0.00331 (38.94%)
At close: Nov 6, 2026

Nascent Pharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
2162149
Market Cap Growth
26.50%-85.56%-72.61%430.37%-57.01%-69.99%
Enterprise Value
-1823331114
Last Close Price
0.010.031.307.509.7558.05

Price Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Forward PE
-7.007.00---
PS Ratio
1.660.390.864.562.323.99
PB Ratio
--0.832.133.742.681.38

EV Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
EV/Sales Ratio
-8.263.407.126.496.23

Financial Efficiency

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Debt / Equity Ratio
-0.92-9.163.461.301.410.02
Debt / FCF Ratio
36.57-----
Net Debt / Equity Ratio
-0.92-9.133.431.221.100.01
Net Debt / EBITDA Ratio
-1.33-1.50-0.73-0.70-0.24-0.01
Net Debt / FCF Ratio
36.54-6.93-2.35-0.85-0.81-0.02
Asset Turnover
0.140.170.420.450.310.42
Inventory Turnover
2.470.991.781.110.491.37
Quick Ratio
0.120.340.540.431.112.57
Current Ratio
0.140.480.700.701.276.70
Return on Equity (ROE)
--1148.32%-358.87%-343.02%-218.54%-116.40%
Return on Assets (ROA)
-62.52%-36.43%-55.28%-62.95%-84.68%-67.52%
Return on Capital Employed (ROCE)
76.30%747.20%-451.80%-146.40%-446.90%-87.80%

Yields

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Nov '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Earnings Yield
-2416.03%-1172.96%-259.58%-57.98%-224.36%-64.10%
FCF Yield
14.40%-158.94%-68.66%-38.14%-50.47%-38.22%
Buyback Yield / Dilution
-608.91%-252.66%-165.79%-470.01%-71.71%-45.69%